Jin Medical International Ltd. (ZJYL) Return on equity 2021–2025
Jin Medical International Ltd. (ZJYL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.0%FY2025 · since FY2021: 18.8% → 4.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.0% | -8.7 pp |
| FY2024 | 12.8% | +0.8 pp |
| FY2023 | 12.0% | -5.8 pp |
| FY2022 | 17.8% | -1.0 pp |
| FY2021 | 18.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ZJYL financial trends
ZJYL RevenueZJYL Net incomeZJYL Net marginZJYL Gross profitZJYL Gross marginZJYL Operating incomeZJYL Operating marginZJYL Operating cash flowZJYL Free cash flowZJYL Capital expendituresZJYL Stock buybacksZJYL Dividends paidZJYL Total assetsZJYL Total liabilitiesZJYL Shareholders’ equityZJYL overview →